These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 6291221)
1. Serological analysis of recent type O foot-and-mouth disease virus isolates from Europe. Rweyemamu MM; Ouldridge EJ Vet Rec; 1982 Aug; 111(8):163-5. PubMed ID: 6291221 [No Abstract] [Full Text] [Related]
2. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783 [TBL] [Abstract][Full Text] [Related]
3. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F; Parry NR J Gen Virol; 1989 Jun; 70 ( Pt 6)():1483-91. PubMed ID: 2471811 [TBL] [Abstract][Full Text] [Related]
4. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of serological and biochemical methods for strain differentiation of foot-and-mouth disease type A viruses. Armstrong RM; Samuel AR; Carpenter WC; Kant R; Knowles NJ Vet Microbiol; 1994 Apr; 39(3-4):285-98. PubMed ID: 8042276 [TBL] [Abstract][Full Text] [Related]
6. Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus. Ouldridge EJ; Barnett PV; Parry NR; Syred A; Head M; Rweyemamu MM J Gen Virol; 1984 Jan; 65 ( Pt 1)():203-7. PubMed ID: 6198448 [TBL] [Abstract][Full Text] [Related]
7. Serological comparison of type A foot and mouth disease virus isolates from Thailand. Doughty WJ; Lunt RA; Lingchongsubonkoch W; Gleeson LJ; Kongthon A Rev Sci Tech; 1995 Sep; 14(3):547-55. PubMed ID: 8593389 [TBL] [Abstract][Full Text] [Related]
8. Sequence identification of antigenic variants in plaque isolates of foot-and-mouth disease virus. Meyer RF; Brown F J Virol Methods; 1995 Oct; 55(2):281-3. PubMed ID: 8537465 [TBL] [Abstract][Full Text] [Related]
9. A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins. Meloen RH; Briaire J J Gen Virol; 1980 Nov; 51(Pt 1):107-16. PubMed ID: 6257830 [TBL] [Abstract][Full Text] [Related]
10. Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. Crowther JR; Farias S; Carpenter WC; Samuel AR J Gen Virol; 1993 Aug; 74 ( Pt 8)():1547-53. PubMed ID: 8393912 [TBL] [Abstract][Full Text] [Related]
11. Foot-and-mouth disease and its antigens. Bachrach HL Adv Exp Med Biol; 1985; 185():27-46. PubMed ID: 2416203 [TBL] [Abstract][Full Text] [Related]
12. An indirect sandwich enzyme labelled immunosorbent assay for the detection of foot and mouth disease virus immunizing antigen in tissue culture harvests. Ouldridge EJ; Barnett PV; Hingley PJ; Rweyemamu MM J Biol Stand; 1984 Oct; 12(4):339-51. PubMed ID: 6098580 [TBL] [Abstract][Full Text] [Related]
13. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793 [TBL] [Abstract][Full Text] [Related]
14. A micro-enzyme-lavelled immunosorbent assay (MICORELISA) for the detection of foot-and-mouth disease virus antigen and antibody. Rai A; Lahiri DK Acta Virol; 1981 Jan; 25(1):49-52. PubMed ID: 6112866 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antigenic variation within type-A foot and mouth disease virus isolates from Asia. Rweyemamu MM; Ouldridge EJ; Head M; Purse F J Biol Stand; 1984; 12(2):191-4. PubMed ID: 6203914 [TBL] [Abstract][Full Text] [Related]
16. Sources of variations encountered during the selection and production of three strains of FMD virus for the development of vaccine for use in Nigeria. Preston KJ; Owens H; Mowat GN J Biol Stand; 1982 Jan; 10(1):35-45. PubMed ID: 6279666 [No Abstract] [Full Text] [Related]
17. [Changes in antigen properties of foot-and-mouth disease virus during several passages]. Salajov EL; Avilov VS; Revenkov AG Bull Off Int Epizoot; 1972; 77(5):935-40. PubMed ID: 4350009 [No Abstract] [Full Text] [Related]
18. [Antigenic properties of strains of A 22 foot-and-mouth disease virus isolated in epizootic conditions]. Salajov EL; Antoniouk VP Bull Off Int Epizoot; 1972; 77(5):929-34. PubMed ID: 4350008 [No Abstract] [Full Text] [Related]
19. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. Mateu MG; MartÃnez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261 [TBL] [Abstract][Full Text] [Related]
20. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]